Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
about
Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's DiseaseHolocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effectsDo CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.Cognitive decline in Parkinson disease.Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.'From past to future' - deciphering the molecular basis of Alzheimer's disease through the pages of the Journal of Neurochemistry.199 years of Parkinson disease - what have we learned and what is the path to the future?Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.Opportunities and Challenges of Multiplex Assays: A Machine Learning Perspective.A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.Potential clinical utility of multiple system atrophy biomarkers.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
P2860
Q26744782-E25EADC5-6D99-4C26-8530-891ABC0F0984Q33734084-87D7BD93-E56C-42C8-9007-C710F410B6D8Q37494873-56810D0B-0DF9-4C89-AB56-5064DDA85541Q38653383-B22A1F8F-7030-4BEB-A413-349AC4234628Q38751099-22294DD2-36EC-4A64-A78B-6D6B6204CEE3Q38761739-B1A1AC1B-FE11-4FFF-9EF1-910543942B32Q38782451-7DA4B1C7-1EC7-41A6-8FE2-1DA6D60CB178Q38825770-EDE36E3C-4091-4EDB-99AE-0ECE90B51B28Q38853776-CDA4B96C-B0B8-4E85-BDF5-E6BCCDE3FB42Q39146393-FA41FB79-4DBD-4C4D-8F30-85E14D34696BQ39451637-CE88B3D5-5B69-4973-9D11-A450E265D592Q40604774-8584AEEB-9A55-474D-B8FF-FF7EAD75C0BEQ47587631-DA58445C-7140-456F-8F26-AF8FCD8D7DDCQ47657093-33295A1E-CD42-4517-92A8-ABB19EB36A67Q47663712-E3FD4C0C-5886-4D83-BC13-CADACD1E8640Q49987358-328EB3F6-9BCA-4385-A9CA-2CA82D7773A4Q53512229-F60B62AB-B0A4-4DF8-9C60-48F994006543Q54982491-EF5119B1-7A15-47FD-9B3E-B45E515D9976
P2860
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biological confounders for the ...... disease and related disorders.
@en
type
label
Biological confounders for the ...... disease and related disorders.
@en
prefLabel
Biological confounders for the ...... disease and related disorders.
@en
P2093
P2860
P50
P356
P1476
Biological confounders for the ...... disease and related disorders.
@en
P2093
Irena Rektorova
Lucia Farotti
Lucilla Parnetti
Maria Pikkarainen
Milica G Kramberger
Per Svenningsson
Walter J Schulz-Schaeffer
P2860
P304
P356
10.1111/JNC.13390
P407
P478
139 Suppl 1
P577
2015-10-10T00:00:00Z